Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

IBD

The changing epidemiology of IBD

A new study reports on the changing burden of IBD, with accelerating incidence in newly industrialized countries and a high burden in Western countries, although the incidence is stabilizing and even decreasing in some of these regions. This new systematic review examined population-based studies published from 1990 to 2016 that reported the incidence or prevalence of either Crohn's disease or ulcerative colitis, including 147 studies in the systematic review. The highest reported prevalence of IBD was in Europe and North America, with prevalence exceeding 0.3% in North America, Oceania and many European countries. Since 1990, the incidence in newly industrialized countries (in Africa, Asia and South America) has been increasing.

References

  1. 1

    Ng, S. C. et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet http://dx.doi.org/10.1016/S0140-6736(17)32448-0 (2017)

Download references

Authors

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ray, K. The changing epidemiology of IBD. Nat Rev Gastroenterol Hepatol 14, 690 (2017). https://doi.org/10.1038/nrgastro.2017.159

Download citation

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing